ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2017

Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study.

Tatsuya Fukuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.